SKC – Macquarie rates the stock as Outperform
Macquarie retains its Outperform rating with the price target rising to NZ$4.05 from NZ$3.75.
Read MoreMacquarie retains its Outperform rating with the price target rising to NZ$4.05 from NZ$3.75.
Read MoreThe Add rating is unchanged and the target price is increased to $1.90 from $1.80.
Read MoreThe risks are estimated to be lower for CSR, given a high level of vertical integration. The Buy rating and $7.40 target are maintained.
Read MoreMorgans downgrades APN Industria REIT’s rating to a Hold from Add on recent share price strength. The price target is increased to $3.28 from $3.17.
Read MoreNeutral maintained. Target rises to $13.00 from $11.70, driven by upgrades to FY22 earnings estimates.
Read MoreThe Neutral rating and $42.30 target price are maintained.
Read MoreThe target is increased to $15.83 from $13.31, as the broker adds in more details around MVE. For now, the Hold recommendation is unchanged.
Read MoreThe broker’s preference is for Goodman Group ((GMG)) as current conditions are favouring developers and valuations for that stock now more conservative. Target is raised to $3.72 from $3.54.
Read MoreCredit Suisse maintains an Outperform rating and $40 target and expects more than a -$1bn reduction in net debt in FY21.
Read MoreNeutral maintained. Target is $0.32.
Read MoreMorgans initiates coverage of Peter Warren Automotive with an Add rating and $4.05 target price.
Read MoreThe broker retains an Outperform rating and $23 target.
Read MoreThe Add rating is maintained and the target lifts to $5.01 from $4.17.
Read MoreValuation remains attractive and the broker retains a Buy rating. Target is $0.70.
Read MoreCredit Suisse retains an Outperform rating and increases the target to $13.45 from $10.40.
Read MoreThe Add rating and $1.80 target are maintained.
Read MoreThe broker was pleased the commitment to the prior 35/90 strategy has been maintained. Buy rating and $47 target retained.
Read MoreIn adjusting forward earnings estimates for the halving of equity production and strengthening of the balance sheet, the analyst lowers the target price to $0.13 from $0.15. The Hold rating is maintained.
Read MoreThe broker reiterates the Sell rating and raises the target to $37 from $36, acknowledging the product has resonated strongly but success was always going to attract competition.
Read MoreThe Add rating is maintained and the target price is increased to $10 from $9.99.
Read MoreOutperform maintained. Target is reduced to $0.65 from $0.80.
Read MoreCredit Suisse maintains the Underperform rating and believes the share price doesn’t adequately reflect the risk of further covid disruptions. The target is kept at $4.15.
Read MoreNeutral rating with a target price of $3.10.
Read MoreThe target price is increased to $34 from $33.50 and the Outperform rating is maintained.
Read MoreMacquarie upgrades to Outperform from Neutral. Target is raised to $20.75 from $20.05.
Read MoreCredit Suisse reinstates coverage with a Neutral rating and $5.40 target.
Read MoreMorgans increases the price target to $5.10 from $4.92. Hold is maintained.
Read MoreOutperform rating with a target of $17.50.
Read MoreThe Neutral rating is unchanged and the target falls to $225 from $230.
Read MoreThe Add rating is unchanged. The target price rises to 6.50 from $6.15.
Read MoreSell rating maintained. Target is reduced to $7.60 from $10.10.
Read MoreThe target price is increased to $17.39 from $16.86 and the Hold rating is maintained.
Read MoreAfter various adjustments, overall EPS forecast revisions result in the target moving to $312 from $296. The Outperform rating is maintained.
Read MoreBuy rating and $1.30 target unchanged.
Read MoreThe Hold rating is unchanged as the analyst feels a good portion of the recovery is priced-in. The target is increased to $4.79 from $4.12.
Read MoreNeutral rating maintained. Target is reduced to $4.77 from $4.80.
Read MoreMacquarie assesses current pricing provides an opportunity and upgrades to Outperform from Neutral. Target edges down to $1.64 from $1.65.
Read MoreMacquarie retains an Outperform rating and raises the target to $1.10 from 95c.
Read MoreThe broker retains a Hold, due to high multiples and a belief that earnings growth will now moderate and cattle prices will eventually fall from current record high levels. The target price is increased to $11.95 from $11.85.
Read MoreMorgans upgrades to Add from Hold and lifts the target price to $20.82 from $19.45.
Read More